1,697
Views
0
CrossRef citations to date
0
Altmetric
Coronavirus

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all, , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Article: 2304974 | Received 24 Aug 2023, Accepted 10 Jan 2024, Published online: 21 Mar 2024